| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 18975 |
| 1 | DEXAMETHASONE | 11787 |
| 2 | DEXAMETHASONE 1.5 MG | 11780 |
| 3 | CYCLOPHOSPHAMIDE | 10780 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 10780 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10780 |
| 6 | LENALIDOMIDE | 9518 |
| 7 | RITUXIMAB | 8422 |
| 8 | CARBOPLATIN | 7633 |
| 9 | PALBOCICLIB | 6803 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 2689 | 0.2245 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 1530 | 0.1831 |
| 2 | CLOZAPINE | 18975 | 0.1500 |
| 3 | ERIBULIN MESYLATE | 538 | 0.1439 |
| 4 | RIBOCICLIB | 4342 | 0.1327 |
| 5 | SACITUZUMAB GOVITECAN | 549 | 0.1136 |
| 6 | DEXRAZOXANE FOR INJECTION | 107 | 0.1133 |
| 7 | TRABECTEDIN | 251 | 0.1068 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 460 | 0.1011 |
| 9 | GRANULOCYTE COLONY STIMULATING FACTOR | 216 | 0.0991 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22721 |
| 1 | Atypical Antipsychotic [EPC] | 21499 |
| 2 | Platinum-based Drug [EPC] | 16156 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 14507 |
| 4 | Alkylating Drug [EPC] | 14289 |
| 5 | Thalidomide Analog [EPC] | 12545 |
| 6 | Kinase Inhibitor [EPC] | 12061 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 10075 |
| 8 | Microtubule Inhibitor [EPC] | 8606 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8514 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 2672 | 0.4565 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 785 | 0.0900 |
| 2 | Endoglycosidase [EPC] | 132 | 0.0712 |
| 3 | Topoisomerase Inhibitor [EPC] | 5470 | 0.0711 |
| 4 | Provitamin D2 Compound [EPC] | 2105 | 0.0707 |
| 5 | Estrogen Receptor Antagonist [EPC] | 2554 | 0.0630 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1334 | 0.0597 |
| 7 | Platinum-based Drug [EPC] | 16156 | 0.0590 |
| 8 | Alkylating Drug [EPC] | 14289 | 0.0586 |
| 9 | BCL-2 Inhibitor [EPC] | 3635 | 0.0578 |